Cargando…
Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study
BACKGROUND: Antiretroviral therapy (ART) scale-up in sub-Saharan Africa combined with weak routine virological monitoring has driven increasing HIV drug resistance. We investigated ART failure, drug resistance, and early mortality among patients with HIV admitted to hospital in Malawi. METHODS: This...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487765/ https://www.ncbi.nlm.nih.gov/pubmed/32890497 http://dx.doi.org/10.1016/S2352-3018(20)30172-7 |
_version_ | 1783581555474563072 |
---|---|
author | Gupta-Wright, Ankur Fielding, Katherine van Oosterhout, Joep J Alufandika, Melanie Grint, Daniel J Chimbayo, Elizabeth Heaney, Judith Byott, Matthew Nastouli, Eleni Mwandumba, Henry C Corbett, Elizabeth L Gupta, Ravindra K |
author_facet | Gupta-Wright, Ankur Fielding, Katherine van Oosterhout, Joep J Alufandika, Melanie Grint, Daniel J Chimbayo, Elizabeth Heaney, Judith Byott, Matthew Nastouli, Eleni Mwandumba, Henry C Corbett, Elizabeth L Gupta, Ravindra K |
author_sort | Gupta-Wright, Ankur |
collection | PubMed |
description | BACKGROUND: Antiretroviral therapy (ART) scale-up in sub-Saharan Africa combined with weak routine virological monitoring has driven increasing HIV drug resistance. We investigated ART failure, drug resistance, and early mortality among patients with HIV admitted to hospital in Malawi. METHODS: This observational cohort study was nested within the rapid urine-based screening for tuberculosis to reduce AIDS-related mortality in hospitalised patients in Africa (STAMP) trial, which recruited unselected (ie, irrespective of clinical presentation) adult (aged ≥18 years) patients with HIV-1 at admission to medical wards. Patients were included in our observational cohort study if they were enrolled at the Malawi site (Zomba Central Hospital) and were taking ART for at least 6 months at admission. Patients who met inclusion criteria had frozen plasma samples tested for HIV-1 viral load. Those with HIV-1 RNA of at least 1000 copies per mL had drug resistance testing by ultra-deep sequencing, with drug resistance defined as intermediate or high-level resistance using the Stanford HIVDR program. Mortality risk was calculated 56 days from enrolment. Patients were censored at death, at 56 days, or at last contact if lost to follow-up. The modelling strategy addressed the causal association between HIV multidrug resistance and mortality, excluding factors on the causal pathway (most notably, CD4 cell count, clinical signs of advanced HIV, and poor functional and nutritional status). FINDINGS: Of 1316 patients with HIV enrolled in the STAMP trial at the Malawi site between Oct 26, 2015, and Sept 19, 2017, 786 had taken ART for at least 6 months. 252 (32%) of 786 patients had virological failure (viral load ≥1000 copies per mL). Mean age was 41·5 years (SD 11·4) and 528 (67%) of 786 were women. Of 237 patients with HIV drug resistance results available, 195 (82%) had resistance to lamivudine, 128 (54%) to tenofovir, and 219 (92%) to efavirenz. Resistance to at least two drugs was common (196, 83%), and this was associated with increased mortality (adjusted hazard ratio 1·7, 95% CI 1·2–2·4; p=0·0042). INTERPRETATION: Interventions are urgently needed and should target ART clinic, hospital, and post-hospital care, including differentiated care focusing on patients with advanced HIV, rapid viral load testing, and routine access to drug resistance testing. Prompt diagnosis and switching to alternative ART could reduce early mortality among inpatients with HIV. FUNDING: Joint Global Health Trials Scheme of the Medical Research Council, UK Department for International Development, and Wellcome Trust. |
format | Online Article Text |
id | pubmed-7487765 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier B.V |
record_format | MEDLINE/PubMed |
spelling | pubmed-74877652020-09-18 Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study Gupta-Wright, Ankur Fielding, Katherine van Oosterhout, Joep J Alufandika, Melanie Grint, Daniel J Chimbayo, Elizabeth Heaney, Judith Byott, Matthew Nastouli, Eleni Mwandumba, Henry C Corbett, Elizabeth L Gupta, Ravindra K Lancet HIV Articles BACKGROUND: Antiretroviral therapy (ART) scale-up in sub-Saharan Africa combined with weak routine virological monitoring has driven increasing HIV drug resistance. We investigated ART failure, drug resistance, and early mortality among patients with HIV admitted to hospital in Malawi. METHODS: This observational cohort study was nested within the rapid urine-based screening for tuberculosis to reduce AIDS-related mortality in hospitalised patients in Africa (STAMP) trial, which recruited unselected (ie, irrespective of clinical presentation) adult (aged ≥18 years) patients with HIV-1 at admission to medical wards. Patients were included in our observational cohort study if they were enrolled at the Malawi site (Zomba Central Hospital) and were taking ART for at least 6 months at admission. Patients who met inclusion criteria had frozen plasma samples tested for HIV-1 viral load. Those with HIV-1 RNA of at least 1000 copies per mL had drug resistance testing by ultra-deep sequencing, with drug resistance defined as intermediate or high-level resistance using the Stanford HIVDR program. Mortality risk was calculated 56 days from enrolment. Patients were censored at death, at 56 days, or at last contact if lost to follow-up. The modelling strategy addressed the causal association between HIV multidrug resistance and mortality, excluding factors on the causal pathway (most notably, CD4 cell count, clinical signs of advanced HIV, and poor functional and nutritional status). FINDINGS: Of 1316 patients with HIV enrolled in the STAMP trial at the Malawi site between Oct 26, 2015, and Sept 19, 2017, 786 had taken ART for at least 6 months. 252 (32%) of 786 patients had virological failure (viral load ≥1000 copies per mL). Mean age was 41·5 years (SD 11·4) and 528 (67%) of 786 were women. Of 237 patients with HIV drug resistance results available, 195 (82%) had resistance to lamivudine, 128 (54%) to tenofovir, and 219 (92%) to efavirenz. Resistance to at least two drugs was common (196, 83%), and this was associated with increased mortality (adjusted hazard ratio 1·7, 95% CI 1·2–2·4; p=0·0042). INTERPRETATION: Interventions are urgently needed and should target ART clinic, hospital, and post-hospital care, including differentiated care focusing on patients with advanced HIV, rapid viral load testing, and routine access to drug resistance testing. Prompt diagnosis and switching to alternative ART could reduce early mortality among inpatients with HIV. FUNDING: Joint Global Health Trials Scheme of the Medical Research Council, UK Department for International Development, and Wellcome Trust. Elsevier B.V 2020-09-02 /pmc/articles/PMC7487765/ /pubmed/32890497 http://dx.doi.org/10.1016/S2352-3018(20)30172-7 Text en © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Articles Gupta-Wright, Ankur Fielding, Katherine van Oosterhout, Joep J Alufandika, Melanie Grint, Daniel J Chimbayo, Elizabeth Heaney, Judith Byott, Matthew Nastouli, Eleni Mwandumba, Henry C Corbett, Elizabeth L Gupta, Ravindra K Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study |
title | Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study |
title_full | Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study |
title_fullStr | Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study |
title_full_unstemmed | Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study |
title_short | Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study |
title_sort | virological failure, hiv-1 drug resistance, and early mortality in adults admitted to hospital in malawi: an observational cohort study |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487765/ https://www.ncbi.nlm.nih.gov/pubmed/32890497 http://dx.doi.org/10.1016/S2352-3018(20)30172-7 |
work_keys_str_mv | AT guptawrightankur virologicalfailurehiv1drugresistanceandearlymortalityinadultsadmittedtohospitalinmalawianobservationalcohortstudy AT fieldingkatherine virologicalfailurehiv1drugresistanceandearlymortalityinadultsadmittedtohospitalinmalawianobservationalcohortstudy AT vanoosterhoutjoepj virologicalfailurehiv1drugresistanceandearlymortalityinadultsadmittedtohospitalinmalawianobservationalcohortstudy AT alufandikamelanie virologicalfailurehiv1drugresistanceandearlymortalityinadultsadmittedtohospitalinmalawianobservationalcohortstudy AT grintdanielj virologicalfailurehiv1drugresistanceandearlymortalityinadultsadmittedtohospitalinmalawianobservationalcohortstudy AT chimbayoelizabeth virologicalfailurehiv1drugresistanceandearlymortalityinadultsadmittedtohospitalinmalawianobservationalcohortstudy AT heaneyjudith virologicalfailurehiv1drugresistanceandearlymortalityinadultsadmittedtohospitalinmalawianobservationalcohortstudy AT byottmatthew virologicalfailurehiv1drugresistanceandearlymortalityinadultsadmittedtohospitalinmalawianobservationalcohortstudy AT nastoulieleni virologicalfailurehiv1drugresistanceandearlymortalityinadultsadmittedtohospitalinmalawianobservationalcohortstudy AT mwandumbahenryc virologicalfailurehiv1drugresistanceandearlymortalityinadultsadmittedtohospitalinmalawianobservationalcohortstudy AT corbettelizabethl virologicalfailurehiv1drugresistanceandearlymortalityinadultsadmittedtohospitalinmalawianobservationalcohortstudy AT guptaravindrak virologicalfailurehiv1drugresistanceandearlymortalityinadultsadmittedtohospitalinmalawianobservationalcohortstudy |